"Banner Alzheimer’s Institute is committed to ending Alzheimer’s before we lose another generation. You’ll find Banner Alzheimer’s Institute at two locations in the Phoenix area. At these centers, people with Alzheimer’s/dementia and their families access a new standard of care that brings together innovative therapies, advanced treatments and valuable resources. Learn more about our services and care."

During the past decade, Banner Alzheimer's Institute conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 31 clinical trials were completed, i.e. on average, 73.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 19 clinical trials were completed. i.e. 118.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Banner Alzheimer's Institute" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Pfizer" with 7 trials sponsored, "Avid Radiopharmaceuticals" with 6 trials sponsored, "University of Southern California" with 6 trials sponsored and "Biogen" with 6 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Banner Alzheimer's Institute" #1 collaborator was "National Institute on Aging (NIA)" with 13 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 6 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 4 trials as a collaborator, "Northern California Institute of Research and Education" with 3 trials as a collaborator and "Pfizer" with 3 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Banner Alzheimer's Institute" are "Alzheimer's Disease" (36 trials), "Alzheimer Disease" (23 trials), "Dementia" (3 trials), "Mild Cognitive Impairment" (3 trials) and "Alzheimer's Disease (AD)" (2 trials). Many other conditions were trialed in "Banner Alzheimer's Institute" in a lesser frequency.

Most popular intervention types in "Banner Alzheimer's Institute" are "Drug" (62 trials), "Biological" (4 trials), "Other" (4 trials), "Procedure" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Flortaucipir F18" (5 trials), "Gantenerumab" (4 trials), "Aducanumab" (3 trials) and "Bapineuzumab 0.5 mg/kg" (3 trials). Other intervention names were less common.

The vast majority of trials in "Banner Alzheimer's Institute" are 72 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Banner Alzheimer's Institute". undefined are not yet recruiting, 13 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Banner Alzheimer's Institute, 1 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Banner Alzheimer's Institute, 3 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Banner Alzheimer's Institute has several departments that took part in Clinical trials: "Banner MD Anderson Cancer Center" - 5 trials